All patient-derived AML samples expressed HLA class I and costimulatory molecules (Figure S7) and were strongly recognized by an alloreactive HLA-B*07:02-specific T-cell clone (Figure 5C). This evidence concerns the gene HLA-B and acute myeloid leukemia.